602 related articles for article (PubMed ID: 22914174)
1. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
van der Touw W; Burrell B; Lal G; Bromberg JS
Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
[TBL] [Abstract][Full Text] [Related]
2. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance.
Lal G; Nakayama Y; Sethi A; Singh AK; Burrell BE; Kulkarni N; Brinkman CC; Iwami D; Zhang T; Bromberg JS
Transplantation; 2015 Sep; 99(9):1817-28. PubMed ID: 25839706
[TBL] [Abstract][Full Text] [Related]
4. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48.
Yang TY; Sun Y; Langnas AN; Zhao Y
Clin Immunol; 2003 Feb; 106(2):148-54. PubMed ID: 12672405
[TBL] [Abstract][Full Text] [Related]
6. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells.
Nathan MJ; Yin D; Eichwald EJ; Bishop DK
Am J Transplant; 2002 Apr; 2(4):323-32. PubMed ID: 12118853
[TBL] [Abstract][Full Text] [Related]
7. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3039. PubMed ID: 30740108
[TBL] [Abstract][Full Text] [Related]
8. Role of natural killer cell subsets in cardiac allograft rejection.
McNerney ME; Lee KM; Zhou P; Molinero L; Mashayekhi M; Guzior D; Sattar H; Kuppireddi S; Wang CR; Kumar V; Alegre ML
Am J Transplant; 2006 Mar; 6(3):505-13. PubMed ID: 16468959
[TBL] [Abstract][Full Text] [Related]
9. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
10. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
Hancock WW; Sayegh MH; Zheng XG; Peach R; Linsley PS; Turka LA
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13967-72. PubMed ID: 8943044
[TBL] [Abstract][Full Text] [Related]
11. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts.
Fabritius C; Ritschl PV; Resch T; Roth M; Ebner S; Günther J; Mellitzer V; Nguyen AV; Pratschke J; Sauter M; Klingel K; Kotsch K
Am J Transplant; 2017 Dec; 17(12):3199-3209. PubMed ID: 28805342
[TBL] [Abstract][Full Text] [Related]
13. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
15. Innate NK cells and macrophages recognize and reject allogeneic nonself in vivo via different mechanisms.
Liu W; Xiao X; Demirci G; Madsen J; Li XC
J Immunol; 2012 Mar; 188(6):2703-11. PubMed ID: 22327074
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo.
Bingaman AW; Ha J; Durham MM; Waitze SY; Tucker-Burden C; Cowan SR; Pearson TC; Larsen CP
Transplantation; 2001 Oct; 72(7):1286-92. PubMed ID: 11602857
[TBL] [Abstract][Full Text] [Related]
18. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection.
El-Sawy T; Belperio JA; Strieter RM; Remick DG; Fairchild RL
Circulation; 2005 Jul; 112(3):320-31. PubMed ID: 15998678
[TBL] [Abstract][Full Text] [Related]
20. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
Chen Y; Heeger PS; Valujskikh A
J Immunol; 2004 May; 172(9):5456-66. PubMed ID: 15100287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
